The global tissue diagnostics market was valued at US$ 32.0 Bn in 2021 and is set to expand at a healthy CAGR of 12.8% during 2022-2032, with a market valuation of US$ 120.2 Bn by 2032.
“Upsurge in the cancer incidences and rising presence of various medical and biotechnology firms across the world is expected to uplift the tissue diagnostics market growth.”
A group of human cells that play an important role in executing several biological functions that are crucial for other healthy functions in the human body are referred to as tissues. Tissue diagnostics is an important field of diagnostics research. The tissue sample explains several aspects of the different biological situations.
Tissue diagnostics have played a major role in the field of cancer analysis and diagnostics. It helps researchers and scientists to identify the presence of cancer by examining the tissue samples. It is also gaining popularity in the different diagnostic fields. In the leading pharmaceutical companies, the study of different chronic diseases’ origin and treatment is carried out. Due to this tissue diagnostics are gaining more popularity in other diagnostics areas.
| Data Points | Key Statistics |
|---|---|
| Tissue Diagnostics Market Size in 2021 | US$ 32.0 Billion |
| Tissue Diagnostics Market Size in 2032 | US$ 120.2 Billion |
| Tissue Diagnostics Market CAGR (2022 to 2032) | 12.8% |
The increasing incidence and prevalence of various types of cancer, such as lung cancer and breast cancer, are expected to boost the tissue diagnostics market over the forecast period.
Additionally, innovations in devices to detect the type of cancerous tissue, a spike in technical enhancements that support the improved imaging of hazardous cells, and a rise in the precision of the outcome could help the tissue diagnostics market in achieving growth throughout the forecast period. Furthermore, increased government and private organizations’ initiatives to create awareness to identify and prevent early cancer are predicted to propel market expansion in the projected years.
Moreover, improved infrastructure of diagnostics laboratories in developed countries is expected to boost the market in the near future. Owing to the growing disposable income of the populace, the spending capability of people on health has increased. Thus, people concerned about their health are highly spending money on diagnostic treatments, even for minor symptoms. This will boost market demand.
On the basis of geographies, the global tissue diagnostics market is divided into seven major regions- North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
The tissue diagnostic market in North America is expected to maintain its hold during the forecast period followed by Europe and the Asia Pacific. Owing to the factors such as high spending on research and development activities in the biotechnology and medical equipment organizations as well as the extensive use of novel technologies, the North American region is attributed to boosting the market growth in the upcoming years.
On the other hand, Asia Pacific is anticipated to show rapid growth in the projected period. The upsurge in the medical tourism business in the nations like China and India is expected to increase the demand for diagnosis and treatment in this region. Furthermore, due to the increase in cancer cases and other disorders will further propel the market growth for tissue diagnostics.
Some of the key players operating in the infection control market are Agilent Technologies, Danaher Corporation, F. Hoffmann-La Roche Ltd, BIOMÉRIEUX, Abbott Laboratories, Merck KGaA, General Electric Company (GE Healthcare), BioGenex, Cell Signaling Technology, Inc., and Koninklijke Philips N.V.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 12.8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | US$ Billion for Value |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Region Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The global tissue diagnostics market is anticipated to register a CAGR of 12.8% during the forecast period.
The tissue diagnostics market is projected to be about US$ 120.2 Bn by the end of year 2032.
Explore Similar Insights
Tissue Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
